Role of KCNMA1 gene in breast cancer invasion and metastasis to brain

Divya Khaitan, Umesh T. Sankpal, Babette Weksler, Edward A. Meister, Ignacio A. Romero, Pierre Olivier Couraud, Nagendra S. Ningaraj

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Background: The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is critical for designing therapeutic modalities for reducing the occurrence of metastasis. Although ubiquitously present in most human organs, large-conductance calcium- and voltage-activated potassium channel (BKCa) channels are significantly upregulated in breast cancer cells. In this study we investigated the role of KCNMA1 gene that encodes for the pore-forming α-subunit of BKCa channels in breast cancer metastasis and invasion. Methods: We performed Global exon array to study the expression of KCNMA1 in metastatic breast cancer to brain, compared its expression in primary breast cancer and breast cancers metastatic to other organs, and validated the findings by RT-PCR. Immunohistochemistry was performed to study the expression and localization of BKCa channel protein in primary and metastatic breast cancer tissues and breast cancer cell lines. We performed matrigel invasion, transendothelial migration and membrane potential assays in established lines of normal breast cells (MCF-10A), non-metastatic breast cancer (MCF-7), non-brain metastatic breast cancer cells (MDA-MB-231), and brain-specific metastatic breast cancer cells (MDA-MB-361) to study whether BKCa channel inhibition attenuates breast tumor invasion and metastasis using KCNMA1 knockdown with siRNA and biochemical inhibition with Iberiotoxin (IBTX). Results: The Global exon array and RT-PCR showed higher KCNMA1 expression in metastatic breast cancer in brain compared to metastatic breast cancers in other organs. Our results clearly show that metastatic breast cancer cells exhibit increased BKCa channel activity, leading to greater invasiveness and transendothelial migration, both of which could be attenuated by blocking KCNMA1. Conclusion: Determining the relative abundance of BKCa channel expression in breast cancer metastatic to brain and the mechanism of its action in brain metastasis will provide a unique opportunity to identify and differentiate between low grade breast tumors that are at high risk for metastasis from those at low risk for metastasis. This distinction would in turn allow for the appropriate and efficient application of effective treatments while sparing patients with low risk for metastasis from the toxic side effects of chemotherapy.

Original languageEnglish
Article number258
JournalBMC Cancer
Volume9
DOIs
StatePublished - 29 Jul 2009

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Brain
Genes
Transendothelial and Transepithelial Migration
Brain Neoplasms
Exons
Large-Conductance Calcium-Activated Potassium Channels
Polymerase Chain Reaction
Poisons
Membrane Potentials
Small Interfering RNA
Breast
Immunohistochemistry

Cite this

Khaitan, D., Sankpal, U. T., Weksler, B., Meister, E. A., Romero, I. A., Couraud, P. O., & Ningaraj, N. S. (2009). Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer, 9, [258]. https://doi.org/10.1186/1471-2407-9-258
Khaitan, Divya ; Sankpal, Umesh T. ; Weksler, Babette ; Meister, Edward A. ; Romero, Ignacio A. ; Couraud, Pierre Olivier ; Ningaraj, Nagendra S. / Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. In: BMC Cancer. 2009 ; Vol. 9.
@article{080c757f9c0f426c8868aaa5d7700132,
title = "Role of KCNMA1 gene in breast cancer invasion and metastasis to brain",
abstract = "Background: The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is critical for designing therapeutic modalities for reducing the occurrence of metastasis. Although ubiquitously present in most human organs, large-conductance calcium- and voltage-activated potassium channel (BKCa) channels are significantly upregulated in breast cancer cells. In this study we investigated the role of KCNMA1 gene that encodes for the pore-forming α-subunit of BKCa channels in breast cancer metastasis and invasion. Methods: We performed Global exon array to study the expression of KCNMA1 in metastatic breast cancer to brain, compared its expression in primary breast cancer and breast cancers metastatic to other organs, and validated the findings by RT-PCR. Immunohistochemistry was performed to study the expression and localization of BKCa channel protein in primary and metastatic breast cancer tissues and breast cancer cell lines. We performed matrigel invasion, transendothelial migration and membrane potential assays in established lines of normal breast cells (MCF-10A), non-metastatic breast cancer (MCF-7), non-brain metastatic breast cancer cells (MDA-MB-231), and brain-specific metastatic breast cancer cells (MDA-MB-361) to study whether BKCa channel inhibition attenuates breast tumor invasion and metastasis using KCNMA1 knockdown with siRNA and biochemical inhibition with Iberiotoxin (IBTX). Results: The Global exon array and RT-PCR showed higher KCNMA1 expression in metastatic breast cancer in brain compared to metastatic breast cancers in other organs. Our results clearly show that metastatic breast cancer cells exhibit increased BKCa channel activity, leading to greater invasiveness and transendothelial migration, both of which could be attenuated by blocking KCNMA1. Conclusion: Determining the relative abundance of BKCa channel expression in breast cancer metastatic to brain and the mechanism of its action in brain metastasis will provide a unique opportunity to identify and differentiate between low grade breast tumors that are at high risk for metastasis from those at low risk for metastasis. This distinction would in turn allow for the appropriate and efficient application of effective treatments while sparing patients with low risk for metastasis from the toxic side effects of chemotherapy.",
author = "Divya Khaitan and Sankpal, {Umesh T.} and Babette Weksler and Meister, {Edward A.} and Romero, {Ignacio A.} and Couraud, {Pierre Olivier} and Ningaraj, {Nagendra S.}",
year = "2009",
month = "7",
day = "29",
doi = "10.1186/1471-2407-9-258",
language = "English",
volume = "9",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",

}

Khaitan, D, Sankpal, UT, Weksler, B, Meister, EA, Romero, IA, Couraud, PO & Ningaraj, NS 2009, 'Role of KCNMA1 gene in breast cancer invasion and metastasis to brain', BMC Cancer, vol. 9, 258. https://doi.org/10.1186/1471-2407-9-258

Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. / Khaitan, Divya; Sankpal, Umesh T.; Weksler, Babette; Meister, Edward A.; Romero, Ignacio A.; Couraud, Pierre Olivier; Ningaraj, Nagendra S.

In: BMC Cancer, Vol. 9, 258, 29.07.2009.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Role of KCNMA1 gene in breast cancer invasion and metastasis to brain

AU - Khaitan, Divya

AU - Sankpal, Umesh T.

AU - Weksler, Babette

AU - Meister, Edward A.

AU - Romero, Ignacio A.

AU - Couraud, Pierre Olivier

AU - Ningaraj, Nagendra S.

PY - 2009/7/29

Y1 - 2009/7/29

N2 - Background: The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is critical for designing therapeutic modalities for reducing the occurrence of metastasis. Although ubiquitously present in most human organs, large-conductance calcium- and voltage-activated potassium channel (BKCa) channels are significantly upregulated in breast cancer cells. In this study we investigated the role of KCNMA1 gene that encodes for the pore-forming α-subunit of BKCa channels in breast cancer metastasis and invasion. Methods: We performed Global exon array to study the expression of KCNMA1 in metastatic breast cancer to brain, compared its expression in primary breast cancer and breast cancers metastatic to other organs, and validated the findings by RT-PCR. Immunohistochemistry was performed to study the expression and localization of BKCa channel protein in primary and metastatic breast cancer tissues and breast cancer cell lines. We performed matrigel invasion, transendothelial migration and membrane potential assays in established lines of normal breast cells (MCF-10A), non-metastatic breast cancer (MCF-7), non-brain metastatic breast cancer cells (MDA-MB-231), and brain-specific metastatic breast cancer cells (MDA-MB-361) to study whether BKCa channel inhibition attenuates breast tumor invasion and metastasis using KCNMA1 knockdown with siRNA and biochemical inhibition with Iberiotoxin (IBTX). Results: The Global exon array and RT-PCR showed higher KCNMA1 expression in metastatic breast cancer in brain compared to metastatic breast cancers in other organs. Our results clearly show that metastatic breast cancer cells exhibit increased BKCa channel activity, leading to greater invasiveness and transendothelial migration, both of which could be attenuated by blocking KCNMA1. Conclusion: Determining the relative abundance of BKCa channel expression in breast cancer metastatic to brain and the mechanism of its action in brain metastasis will provide a unique opportunity to identify and differentiate between low grade breast tumors that are at high risk for metastasis from those at low risk for metastasis. This distinction would in turn allow for the appropriate and efficient application of effective treatments while sparing patients with low risk for metastasis from the toxic side effects of chemotherapy.

AB - Background: The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is critical for designing therapeutic modalities for reducing the occurrence of metastasis. Although ubiquitously present in most human organs, large-conductance calcium- and voltage-activated potassium channel (BKCa) channels are significantly upregulated in breast cancer cells. In this study we investigated the role of KCNMA1 gene that encodes for the pore-forming α-subunit of BKCa channels in breast cancer metastasis and invasion. Methods: We performed Global exon array to study the expression of KCNMA1 in metastatic breast cancer to brain, compared its expression in primary breast cancer and breast cancers metastatic to other organs, and validated the findings by RT-PCR. Immunohistochemistry was performed to study the expression and localization of BKCa channel protein in primary and metastatic breast cancer tissues and breast cancer cell lines. We performed matrigel invasion, transendothelial migration and membrane potential assays in established lines of normal breast cells (MCF-10A), non-metastatic breast cancer (MCF-7), non-brain metastatic breast cancer cells (MDA-MB-231), and brain-specific metastatic breast cancer cells (MDA-MB-361) to study whether BKCa channel inhibition attenuates breast tumor invasion and metastasis using KCNMA1 knockdown with siRNA and biochemical inhibition with Iberiotoxin (IBTX). Results: The Global exon array and RT-PCR showed higher KCNMA1 expression in metastatic breast cancer in brain compared to metastatic breast cancers in other organs. Our results clearly show that metastatic breast cancer cells exhibit increased BKCa channel activity, leading to greater invasiveness and transendothelial migration, both of which could be attenuated by blocking KCNMA1. Conclusion: Determining the relative abundance of BKCa channel expression in breast cancer metastatic to brain and the mechanism of its action in brain metastasis will provide a unique opportunity to identify and differentiate between low grade breast tumors that are at high risk for metastasis from those at low risk for metastasis. This distinction would in turn allow for the appropriate and efficient application of effective treatments while sparing patients with low risk for metastasis from the toxic side effects of chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=68949210502&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-9-258

DO - 10.1186/1471-2407-9-258

M3 - Article

C2 - 19640305

AN - SCOPUS:68949210502

VL - 9

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 258

ER -

Khaitan D, Sankpal UT, Weksler B, Meister EA, Romero IA, Couraud PO et al. Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer. 2009 Jul 29;9. 258. https://doi.org/10.1186/1471-2407-9-258